1. Banta, Karl L, Xu, Xiaozheng, Chitre, Avantika S, Chiang, Eugene Y, Mellman, Ira. . Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses. In Immunity, 55, 512-526.e9. doi:10.1016/j.immuni.2022.02.005. https://pubmed.ncbi.nlm.nih.gov/35263569/
2. Nie, Daqing, Li, Hongbo, Yan, Guixiu, He, Zhaomin, Zhou, Wenyu. 2016. Gene-gene interaction between CD40 and CD226 gene on systemic lupus erythematosus in the Chinese Han population. In Rheumatology international, 36, 1657-1662. doi:. https://pubmed.ncbi.nlm.nih.gov/27722794/
3. Qiu, Zhi-Xin, Peng, Ying, Li, Wei-Min. 2015. CD226 gene polymorphisms are associated with non-small-cell lung cancer in the Chinese Han population. In Therapeutics and clinical risk management, 11, 1259-64. doi:10.2147/TCRM.S90365. https://pubmed.ncbi.nlm.nih.gov/26346602/
4. Xie, Yang, Zhang, Yuan, Zhu, Tianxiao, Bian, Ka, Lu, Lianjun. 2022. CD226 Deficiency Alleviates Murine Allergic Rhinitis by Suppressing Group 2 Innate Lymphoid Cell Responses. In Mediators of inflammation, 2022, 1756395. doi:10.1155/2022/1756395. https://pubmed.ncbi.nlm.nih.gov/35846105/
5. Zhang, Yuan, Xu, Xuexue, Ma, Jingchang, Cheng, Kun, Zhuang, Ran. 2022. Loss of CD226 protects apolipoprotein E-deficient mice from diet-induced atherosclerosis. In Biochimica et biophysica acta. Molecular basis of disease, 1868, 166452. doi:10.1016/j.bbadis.2022.166452. https://pubmed.ncbi.nlm.nih.gov/35618182/